Clinical Trial Update: ToleroMune Grass Follow on Study

View source ↗

Summary

This update indicates that the ToleroMune Grass follow-on clinical trial for grass pollen-induced rhinoconjunctivitis/rgrass allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grass Allergy
• Rhinoconjunctivitis

Drugs mentioned

• ToleroMune Grass

Snippet

Sponsor: Circassia Limited | Conditions: Rhinoconjunctivitis, Grass Allergy | Status: COMPLETED